Year ended March 31	2005	2006	2007	2008	2009	2010 (Forecast: as of Jan 29, 2010)
Net Sales	150,584	157,806	205,859	215,007	140,510	130,800
Operating Income	17,918	28,100	35,326	25,126	-6,823	4,300
Recurring Income	17,486	28,202	34,887	21,050	-6,961	3,400
Net Income	9,386	16,338	19,225	11,336	-6,042	1,700
Total Assets	158,499	175,541	198,862	198,475	156,266	-
Shareholders’ Equity	100,737	117,288	134,193	143,193	132,959	-
Capital Expenditure	14,851	15,398	38,038	21,930	14,923	-
Research & Development	3,175	3,477	3,975	4,396	4,651	-
Shareholders’ Equity to Total	63.6%	66.8%	68.0%	72.1%	85.1%	-
Return on Equity (%)	9.7%	15.0%	15.2%	8.1%	-4.4%	-
Net Income per Share (Yen)	206.80	361.13	142.32*	83.92	-44.73	12.58
Shareholders’ Equity per Share (Yen)	2,243.26	2,603.29	1,000.33	1,059.98	984.22	-
Cash Dividends per Share (Non-consolidated) (Yen)	25.00	32.00	18.00	27.00	8.00	8.00

Year ended March 31	2005	2006	2007	2008	2009	2010 (Forecast: as of Jan 29, 2010)
Net Sales	146,121	153,123	200,100	209,582	136,336	127,100
Including Net Overseas Sales	92,468	102,739	122,940	116,004	81,432	-
Operating Income	16,589	26,817	33,950	24,047	-7,177	3,800
Recurring Income	16,415	27,403	33,584	20,357	-6,850	3,100
Net Income	8,785	15,930	18,602	11,933	-5,782	1,600

Financial Highlights

Consolidated Financial Statements